This inventor holds 1 USPTO granted patent. Top assignee: Vanderbilt University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kevin J Kramer - Innovator in Therapeutic Antibodies for Lung Cancer
Introduction
Kevin J Kramer is a notable inventor based in Nashville, TN. He has made significant contributions to the field of medical research, particularly in the development of therapeutic antibodies aimed at treating lung cancer. His innovative work has the potential to impact the lives of many patients battling this disease.
Latest Patents
Kevin J Kramer holds a patent for "Therapeutic antibodies for treating lung cancer." This patent relates to antibodies and their uses in the treatment of lung cancer, showcasing his commitment to advancing medical science and improving patient outcomes. He has 1 patent to his name.
Career Highlights
Kramer is affiliated with Vanderbilt University, where he conducts research and collaborates with other experts in the field. His work at this prestigious institution allows him to contribute to groundbreaking research and innovation in therapeutic treatments.
Collaborations
One of his notable collaborators is Ivelin Georgiev. Together, they work on advancing the understanding and treatment of lung cancer through innovative research and development.
Conclusion
Kevin J Kramer is a dedicated inventor whose work in therapeutic antibodies represents a significant advancement in the fight against lung cancer. His contributions to medical research continue to inspire and pave the way for future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile